ScoreWhy is Orchid Pharma Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 11.87% and Operating profit at 18.41% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.91
2
With a fall in Net Sales of -8.98%, the company declared Very Negative results in Sep 25
- The company has declared negative results for the last 4 consecutive quarters
- The company has declared negative results in Dec 24 after 2 consecutive negative quarters
- PBT LESS OI(Q) At Rs -14.10 cr has Fallen at -213.3% (vs previous 4Q average)
- PAT(Q) At Rs -5.72 cr has Fallen at -126.8% (vs previous 4Q average)
- ROCE(HY) Lowest at 4.28%
3
With ROCE of 2.3, it has a Very Expensive valuation with a 3.2 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -49.42%, its profits have fallen by -56.1%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Orchid Pharma for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Orchid Pharma
-50.35%
-1.02
48.60%
Sensex
8.49%
0.44
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.87%
EBIT Growth (5y)
18.41%
EBIT to Interest (avg)
1.91
Debt to EBITDA (avg)
5.83
Net Debt to Equity (avg)
0.10
Sales to Capital Employed (avg)
0.55
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
20.56%
ROCE (avg)
0.90%
ROE (avg)
4.62%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
68
Industry P/E
32
Price to Book Value
2.79
EV to EBIT
115.03
EV to EBITDA
54.91
EV to Capital Employed
2.62
EV to Sales
4.48
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.27%
ROE (Latest)
4.10%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-29What is not working for the Company
PBT LESS OI(Q)
At Rs -14.10 cr has Fallen at -213.3% (vs previous 4Q average
PAT(Q)
At Rs -5.72 cr has Fallen at -126.8% (vs previous 4Q average
ROCE(HY)
Lowest at 4.28%
OPERATING PROFIT TO INTEREST (Q)
Lowest at -0.40 times
OPERATING PROFIT TO NET SALES(Q)
Lowest at -0.76%
DEBT-EQUITY RATIO(HY)
Highest at 0.22 times
NET SALES(Q)
At Rs 193.52 cr has Fallen at -9.0% (vs previous 4Q average
PBDIT(Q)
Lowest at Rs -1.48 cr.
EPS(Q)
Lowest at Rs -1.13
Loading Valuation Snapshot...
Here's what is not working for Orchid Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -14.10 cr has Fallen at -213.3% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 12.45 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs -5.72 cr has Fallen at -126.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 21.31 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Operating Profit to Interest - Quarterly
Lowest at -0.40 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Operating Profit Margin - Quarterly
Lowest at -0.76% and Fallen
each quarter in the last five quartersMOJO Watch
Company's efficiency has deteriorated
Operating Profit to Sales
Net Sales - Quarterly
At Rs 193.52 cr has Fallen at -9.0% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 212.61 CrMOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs -1.48 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -14.10 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
Earnings per Share (EPS) - Quarterly
Lowest at Rs -1.13
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
Debt-Equity Ratio - Half Yearly
Highest at 0.22 times
in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
